Journal
TALANTA
Volume 175, Issue -, Pages 235-242Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.talanta.2017.07.049
Keywords
Renal cell carcinoma; Cell-SELEX; Aptamer; 786-O
Categories
Funding
- National Natural Science Foundation of China [21575154, 21507156]
- Science and Technology Foundation of Jiangsu Province [BE2016680]
- Science and Technology Foundation of Suzhou [SYG201526]
- CAS/SAFEA International Innovation Teams program
Ask authors/readers for more resources
Renal cell carcinoma (RCC) is the most common form of kidney cancer with poor prognosis. Early diagnosis of RCC would significantly improve patient prognosis and quality of life. In this work, we developed new aptamer probes for RCC by using cell-SELEX (systematic evolution of ligands by exponential enrichment) only after 12 rounds of selection, in which a clear cell renal cell carcinoma (ccRCC) cell line 786-O was used as target cell, and embryonic kidney cell line 293T as negative control cell. The selected aptamers were subjected to flow cytometry and laser confocal fluorescence microscopy to evaluate their binding affinity and selectivity. The dissociation constant K-d values of four selected aptamers are all in the nanomolar range. Aptamer W786-1 with the best binding affinity and a K-d value of 9.4 +/- 2.0 nM was further optimized and its truncated sequence W786-1S showed considerable affinity to 786-O cells. The proteinase and temperature treatment experiment indicated that W786-1 could recognize the target 786-O cells through surface proteins, and remain good binding affinity and excellent selectivity under physiological conditions. Therefore, on the basis of its excellent targeting properties and functional versatility, W786-1 holds great potential to be used as a molecular probe for identifying and targeting RCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available